1. Introduction
===============

T~regs~ play important roles in dominant tolerance and immune homeostasis \[[@B1-pathogens-04-00090],[@B2-pathogens-04-00090]\], and are targeted for human immunotherapy. Therefore, it is essential to study how T~regs~ precisely respond under steady state conditions and inflammatory conditions. Although T~regs~ are conventionally non-producers of inflammatory cytokines, recent reports document the presence of interleukin (IL)-17+Foxp3+ cells in mucosal environments in mice as well as in several human diseases \[[@B3-pathogens-04-00090],[@B4-pathogens-04-00090],[@B5-pathogens-04-00090],[@B6-pathogens-04-00090],[@B7-pathogens-04-00090]\]. This novel subset of cells likely represents an intermediate differentiation stage between Th17 cells and T~regs~. However, the mechanism by which they are induced, and their exact functions remain unknown \[[@B6-pathogens-04-00090],[@B8-pathogens-04-00090]\]. TLR-2 recognizes bacterial lipopeptides, lipoteichoic acid from Gram-positive bacteria, zymosan from yeast cell walls, and the synthetic lipoprotein Pam3CSK4 \[[@B9-pathogens-04-00090]\]. Toll like receptors (TLR)s are generally expressed by the innate immune cells and APC, and play critical roles in host defense \[[@B10-pathogens-04-00090],[@B11-pathogens-04-00090]\]. T lymphocytes, including T~reg~ cells demonstrate Toll-like receptor signaling as well \[[@B12-pathogens-04-00090]\]. TLR-2 polymorphisms are associated with changes in neonatal T~reg~ numbers as well as allergies and atopic dermatitis \[[@B13-pathogens-04-00090]\]. *In vitro*, Pam3CSK4 directly acts on CD4 cells and enhance their IL-17 production during Th17 differentiation \[[@B14-pathogens-04-00090]\]. However, research on TLR-2 signaling in T~regs~ has produced some varied results. Some studies show that TLR-2 ligands reduce Foxp3 expression in T~regs~, and reverse their suppressive functions \[[@B15-pathogens-04-00090],[@B16-pathogens-04-00090]\]. Others show that TLR-2 ligands improve the survival of T~regs~ without reversing their suppressive functions \[[@B17-pathogens-04-00090]\]. By inducing peripheral T~regs~ (pT~regs~), TLR-2 signaling also promotes gut tolerance and not inflammation \[[@B18-pathogens-04-00090]\]. Though some of the above studies imply that suppression by T~regs~ may be overcome by TLR ligand induced DC maturation, and pro-inflammatory cytokine induction in effector cells \[[@B19-pathogens-04-00090],[@B20-pathogens-04-00090]\], whether some of the effects were directly mediated by TLR-2 signaling in T~regs~, remains incompletely defined. Additionally, some data suggest that T~regs~ may play a deleterious role during acute disseminated candidiasis \[[@B21-pathogens-04-00090]\], however we as well as others have previously shown their protective functions during acute OPC and reinfection \[[@B22-pathogens-04-00090],[@B23-pathogens-04-00090],[@B24-pathogens-04-00090]\]. Whether T~regs~ themselves produce effector cytokines was not investigated at the time. In this study, we have shown that during OPC and under Th17 inducing conditions *in vitro*, TLR-2 ligands promoted proliferation and IL-17A induction in Foxp3^+^T~regs~. Increased proliferation was dependent on TLR-2 expression in T~regs~. However, IL-17A production was dependent on TLR-2 signaling in T~regs~ and APC, as well as IL-6 in the milieu. Under Th17 inducing conditions*,* though the presence of IL-6 in the milieu minimally reduced Foxp3 expression, TLR-2 ligand stimulation did not directly reduce Foxp3 expression. The TLR-2 activated T~regs~, which included IL-17 producing T~regs~, retained suppressive activity. Taken together, we have identified the direct role of TLR-2 ligands in promoting proliferation and IL-17A production in T~regs~*,* without affecting their suppressive functions *in vitro* and *in vivo.*

2. Results
==========

2.1. CD4^+^CD25^+^Foxp3^+^ T~regs~ Express IL-17A During Oral *C. Albicans* Infection and Inflammatory Bowel Disease (IBD) *in Vivo*
------------------------------------------------------------------------------------------------------------------------------------

We and others have previously shown that IL-17A is critical for anti-Candidal host resistance \[[@B22-pathogens-04-00090],[@B25-pathogens-04-00090]\], and T~regs~ enhance acute effector Th17 responses and fungal clearance during OPC \[[@B22-pathogens-04-00090],[@B23-pathogens-04-00090]\]. Therefore we monitored the expression of IL-17A in Foxp3+ T~regs~ in the same OPC infection model by orally infecting the Foxp3^GFP^ reporter mice with *C. albicans*. On day 2 after infection, we isolated the cells from spleen, lymphnodes and mouse oral lamina propria and intraepithelial cells (MOIL) isolated from tongue and palatal tissues \[[@B26-pathogens-04-00090]\]. Both CD4^+^Foxp3^−^ effector cells and CD4^+^Foxp3^+^ T~regs~ responded to infection by expressing IL-17A in the draining axillary lymph nodes (ALN), cervical lymph nodes (CLN) and MOIL in infected mice ([Figure 1](#pathogens-04-00090-f001){ref-type="fig"}a). Although there were a few Foxp3+IL-17A+ cells in sham infected mice, CD44^high^ (activated) CD4 cells showed a substantial increase in Foxp3+IL-17A+ cells only in infected mice. However, there was no increase of these cells in spleen ([Figure 1](#pathogens-04-00090-f001){ref-type="fig"}a). We further confirmed the induction of Foxp3+IL-17A+ cells by gating on CD4^+^Foxp3^+^ cells only ([Figure 1](#pathogens-04-00090-f001){ref-type="fig"}b,c). Although a fraction of T~regs~ produced IL-17A on d1 and d2 after infection as shown previously \[[@B22-pathogens-04-00090]\], T~regs~ still increased IL-17A in effector cells, decreased fungal burden, and modulated immunopathology and weight loss in T~reg~ recipients during OPC on d5 (data not shown, \[[@B22-pathogens-04-00090]\]).

![CD4^+^Foxp3^+^ T~regs~ express IL-17A during *C. albicans* infection *in vivo*. (**a**) Foxp3^GFP^ reporter mice were infected with PBS sham or *C. albicans*. On day 2 after infection, the cells from spleen, lymph nodes, and MOIL were isolated and restimulated for cytokine analyses. Flow cytometric plots showing Foxp3 and IL-17A expression, gated on CD4+ cells (top), and CD4+CD44^high^ activated CD4 cells (middle and bottom rows). (**b**) Cells were isolated as in "a". Flow cytometric analyses of IL-17A expression, gating on CD4+Foxp3+ cells in sham or *C. albicans* infected mice. Data represent triplicate experiments.](pathogens-04-00090-g001){#pathogens-04-00090-f001}

Human mucosal Foxp3+T~regs~ express IL-17A in inflammatory conditions, such as periodontitis, psoriasis and IBD \[[@B4-pathogens-04-00090]\]. Therefore, we next tested whether IL-17A^+^Foxp3^+^ cells are induced during IBD in mice. We adoptively transferred CD45.1 Th17 cells into CD45.1 Rag1^−/−^ mice to initiate IBD \[[@B22-pathogens-04-00090],[@B27-pathogens-04-00090]\]. Two weeks after IBD induction, we injected CD4^+^CD25^+^GFP^+^ T~regs~, derived from congenic CD45.2 Foxp3^GFP^ reporter mice. Five days after T~reg~ injection, we isolated spleen, mesenteric lymph nodes (MLN) and mouse gut intraepithelial and lamina propria leukocytes (MGIL) and measured the IL-17A induction upon restimulation *in vitro*. We gated on CD4+Foxp3^−^CD45.1+effector cells and CD4+Foxp3^+^CD45.1-T~regs~ to examine IL-17A induction in these cells. We observed that T~regs~ were able to produce IL-17A, especially in MLN and LP during inflammation *in vivo* ([Figure S1](#app1-pathogens-04-00090){ref-type="app"}a). Despite IL-17A production in T~regs~, the injected T~regs~ still modulated IBD and weight loss in T~reg~ recipients ([Figure S1](#app1-pathogens-04-00090){ref-type="app"}b). Taken together, these data demonstrate that infections and inflammatory conditions can induce IL-17A production in a fraction of Foxp3+T~regs~ *in vivo*, but do not affect their immunomodulatory functions.

2.2. TLR-2 Ligands Directly Induce Proliferation of T~regs~ Independently of TCR Activation
-------------------------------------------------------------------------------------------

As *C. albicans* activates TLR-2 and dectin signaling that promote Th17 responses \[[@B28-pathogens-04-00090]\], we examined whether TLR-2 ligands and dectin ligands induced IL-17A in T~regs~ *in vitro*. We sought to investigate the effects of TLR-2 ligands on highly purified CD4^+^CD25^+^Foxp3^+^ T~regs~ under non-inflammatory and inflammatory conditions. First we examined whether TLR ligands impacted T~regs~ in the absence of TCR activation, but with IL-2 alone. IL-2 stimulation of T~regs~ in the absence of TCR ligation would be akin to non-inflammatory conditions and would induce homeostatic proliferation in T~regs~ \[[@B29-pathogens-04-00090],[@B30-pathogens-04-00090],[@B31-pathogens-04-00090]\]. We isolated CD4^+^ CD25^+^Foxp3^GFP+^ cells (T~reg~) and control CD4^+^CD25^−^Foxp3^GFP−^CD44^l^°^w^ naïve T cells (T~con~) from Foxp3^GFP^ reporter mice ([Figure S2](#app1-pathogens-04-00090){ref-type="app"}), and stimulated them with IL-2 \[[@B30-pathogens-04-00090]\]. This condition also prevented the proliferation of possible contaminating T~cons~ among T~regs~, which expand vigorously with TCR stimulation in cultures. We labeled T~regs~ with cell proliferation dye-670 (CPD-670) and tested their viability and proliferation with and without various TLR ligands. As expected, naïve T~con~ cells died under these conditions in the absence of TCR activation (data not shown). However, IL-2 stimulation alone maintained T~reg~ viability by virtue of constitutive IL-2 receptor expression on T~regs~. On day 4 after stimulation, heat killed *Candida albicans* (HKCA), a natural Tlr-2/Dectin ligand, and Pam3CSK4, a TLR2/6 ligand increased the proliferation of T~regs~ ([Figure 2](#pathogens-04-00090-f002){ref-type="fig"}a). Other TLR ligands, such as Poly A:U (TLR-3) (data not shown), LPS(TLR-4) and Flagellin (TLR-5), showed no effect ([Figure 2](#pathogens-04-00090-f002){ref-type="fig"}a). As TLR-2 ligands have been shown to transiently reduce Foxp3 mRNA expression of TCR activated T~regs~ \[[@B15-pathogens-04-00090]\], we measured Foxp3 expression of T~regs~. HKCA and Pam3CSK4 did not reduce Foxp3 expression in T~regs~ ([Figure 2](#pathogens-04-00090-f002){ref-type="fig"}b). To examine their suppressive capacity, we washed the T~regs~ to remove the TLR-2 ligands, and stimulated them with α-CD3 and APC along with freshly isolated, carboxyfluorescein di-acetate succinimidyl ester (CFSE) labeled CD4^+^CD25^−^ responding cells (T~resp~) in co-cultures. T~resps~ that were stimulated alone without T~regs~ showed increased proliferation (76.2%) compared to T~resps~ that were stimulated with T~regs~ (38.9%) on day 4 after stimulation ([Figure 2](#pathogens-04-00090-f002){ref-type="fig"}c). T~regs~ that were previously stimulated with IL-2 alone, or with Pam3CSK4 or HKCA, were capable of suppressing the proliferation of T~resps~ ([Figure 2](#pathogens-04-00090-f002){ref-type="fig"}c). These data show that TLR-2 ligands, along with IL-2 can induce proliferation of T~regs~ in the absence of TCR signals, without affecting their suppressive capacities. Because T~regs~ responded to TLR-2 ligands without TCR activation, we hypothesized that they might express TLR-2 protein *ex vivo*. We found that both Foxp3^−^ and Foxp3^+^ CD4+ cells from spleen and lymph nodes expressed TLR-2 *ex vivo* ([Figure 2](#pathogens-04-00090-f002){ref-type="fig"}d)*.* Interestingly, TLR-2 expression was markedly increased in mucosal T~regs~ found among MOIL and mouse gut intraepithelial and lamina propria cells (MGIL), implying an important role of TLR-2 in mucosal T~regs~.

![T~regs~ proliferate in response to TLR ligands and IL-2 independently of TCR. (**a**) CPD-670 dilution (proliferation) of T~reg~ cells, with indicated TLR ligands added at the beginning of stimulation; (**b**) Histograms of Foxp3 expression of live T~regs~ that were stimulated as in "a"; (**c**) T~regs~ stimulated with or without TLR-2 ligands as in "a", were isolated and washed after two days. They were restimulated with fresh CFSE-labeled CD4 naive responder (T~resp~) cells in co-cultures. Some T~resp~ cells were not stimulated (d0-unstim) or stimulated alone (+ none). T~resp~ proliferation is shown; (**d**) Foxp3 and TLR-2 expression in CD4 T cells isolated *ex vivo* from indicated tissues. (**a**--**d**) represent three independent experiments.](pathogens-04-00090-g002){#pathogens-04-00090-f002}

2.3. TLR-2 Ligand Mediated Proliferation in T~regs~ is Directly Dependent on TLR-2 Expression on T~regs~
--------------------------------------------------------------------------------------------------------

We then sought to confirm that proliferation induced by TLR-2 ligands was dependent on TLR-2 expression in T~regs~. We isolated T~regs~ from the spleens of WT or Tlr-2^−/−^ mice and stimulated with IL-2 and TLR-2 ligands. On day 3 after stimulation, HKCA and Pam3CSK4 increased the T~reg~ cell numbers in WT T~regs~ but not in Tlr-2^−/−^ T~regs~, showing that they induced proliferation in TLR-2 dependent manner in T~regs~ ([Figure 3](#pathogens-04-00090-f003){ref-type="fig"}a). If TLR-2 signaling induced proliferation of T~regs~ in the absence of TCR ligation or inflammatory cytokines, TLR-2 agonists in gut commensal microbes and other endogenous ligands may also promote T~reg~ proliferation under homeostatic conditions *in vivo*. To test this idea, we examined the frequency of CD4+CD25+Foxp3+ T~regs~ in various organs, including SPLN, MLN, payer's patches (PP), gut lamina propria (LP), and the gut intra epithelial lymphocytes (IEL) in WT and Tlr-2^−/−^ mice, using flow cytometry. We found that the frequency of CD4+CD25+Foxp3+ cells was significantly reduced in Tlr-2^−/−^ mice when compared to the WT mice ([Figure 3](#pathogens-04-00090-f003){ref-type="fig"}b,c). A previous study showed that the frequency of CD4^+^CD25^+^ cells was lower in the peripheral blood of Tlr-2^−/−^ mice than in WT mice \[[@B21-pathogens-04-00090]\]. However, neither Foxp3 expression nor the frequency of thymically derived T~regs~ (tT~regs~) and peripheral T~regs~ (pT~regs~) was examined. Therefore we evaluated the expression of neuropilin-1 (Nrp-1), a marker on tT~regs~ in peripheral organs and mucosal tissues. The frequency of both the T~reg~ populations were decreased slightly in SPLN, but dramatically in CLN, MLN, PP and LP of Tlr-2^−/−^ mice, when compared to the WT mice ([Figure 3](#pathogens-04-00090-f003){ref-type="fig"}d). Interestingly, in payer's patches and the intestinal lamina propria, the reduction of T~regs~ in Tlr-2^−/−^ mice was more pronounced in the Nrp-1^−^ pT~reg~ compartment ([Figure 3](#pathogens-04-00090-f003){ref-type="fig"}d). These results highlight the importance of TLR-2 ligands in promoting tT~reg~ and pT~reg~ homeostatic proliferation under steady-state conditions *in vivo*.

###### 

Pam3CSK4 and HKCA induce proliferation of T~regs~ in a TLR-2 dependent manner. (**a**) Live cell counts (PI^neg^ and FSC^high^) of T~reg~ cells from WT (grey) or Tlr-2^−/−^ (black) mice stimulated with various TLR-2 ligands for three days as in "2a". CD4^+^CD25^+^Foxp3^+^ (**b**), or CD4^+^ Foxp3^+^Nrp1^+^ (**d**), frequencies in WT (left) and Tlr-2^−/−^ (right) cells isolated *ex vivo*. (**c**) Statistical analyses showing T~reg~ frequencies in WT and Tlr-2^−/−^ mice, as determined in "b".
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2.4. TLR-2 Ligands Did Not Reduce Foxp3 Expression, but Induced IL-17A in Foxp3+ T~regs~ under Th17 Conditions *in Vitro*
-------------------------------------------------------------------------------------------------------------------------

We then sought to investigate whether TLR-2 ligands may promote IL-17A in T~regs~ stimulated under Th17 inducing conditions *in vitro.* Although TLR-2 ligands have been shown to reduce Foxp3 expression and suppressive properties in T~regs~ \[[@B15-pathogens-04-00090]\], whether IL-17A is induced in T~regs~ is unknown. However, Strober and colleagues have shown that T~regs~ produce IL-17A in Th17 inducing conditions *in vitro* \[[@B32-pathogens-04-00090]\]. Therefore, we stimulated T~regs~ in co-cultures along with T~cons~ at a ratio of 1:10 under Th17 inducing conditions. T~con~ cells proliferated in to Th17 effectors (T~eff~). As controls, we stimulated T~regs~ in Th0 conditions. To distinguish T~regs~ and T~eff~ in co-cultures, we labeled T~regs~ using CPD670 in addition to CD45.2 congenic marker on T~regs~ in co-cultures ([Figure S3](#app1-pathogens-04-00090){ref-type="app"}a). We gated on CPD670^+^CD45.2^+^T~regs~ ([Figure S3](#app1-pathogens-04-00090){ref-type="app"}a), and examined their proliferation, Foxp3 expression and IL-17A expression. Four days after stimulation, Pam3CSK4 and HKCA increased the proliferation of T~regs~ ([Figure 4](#pathogens-04-00090-f004){ref-type="fig"}a). Although \~20% of the cells lost Foxp3 expression completely, many of these cells were non-proliferating T~regs~, which did not dilute CPD670 ([Figure S3](#app1-pathogens-04-00090){ref-type="app"}b). These cells were found in the presence and the absence of TLR-2 ligands ([Figure S3](#app1-pathogens-04-00090){ref-type="app"}b), likely due to the fact that IL-6 that can transiently reprogram T~regs~ to lose Foxp3 expression \[[@B22-pathogens-04-00090],[@B33-pathogens-04-00090]\]. However, when proliferating T~regs~ were examined, TLR-2 ligands did not lead to reduction in Foxp3 expression ([Figure 4](#pathogens-04-00090-f004){ref-type="fig"}b). As expected, in the absence of IL-2, T~regs~ showed poor survivability and reduced Foxp3 expression (\[[@B30-pathogens-04-00090]\], [Figure 4](#pathogens-04-00090-f004){ref-type="fig"}b). We also observed that a small fraction of the Foxp3+ cells (\~3%) consistently expressed IL-17A ([Figure 4](#pathogens-04-00090-f004){ref-type="fig"}c). However, TLR-2 ligands increased the frequency and the levels of IL-17A substantially ([Figure 4](#pathogens-04-00090-f004){ref-type="fig"}c, upper panel). We did not observe IL-17A expression in control Th0 stimulated T~regs~ ([Figure 4](#pathogens-04-00090-f004){ref-type="fig"}c, upper panel). To verify the specificity of the staining, we used T~regs~ from *Il17a^-/-cre^* mice, which barely showed IL-17A expression ([Figure S4](#app1-pathogens-04-00090){ref-type="app"}). Under Th0 and Th17 polarizing conditions, a small fraction of T~effs~ also induced Foxp3 expression (iT~regs~) ([Figure 4](#pathogens-04-00090-f004){ref-type="fig"}d, upper panel). iT~regs~ that were induced in Th0 conditions did not express IL-17A, while iT~regs~ induced under Th17 polarizing conditions up-regulated IL-17A, similar to natural T~regs~ ([Figure 4](#pathogens-04-00090-f004){ref-type="fig"}d). These data show that both *in vitro* induced iT~regs~ and natural T~regs~ isolated from mice are capable of producing IL-17A under Th17 inducing conditions.

###### 

TLR-2 ligands induce proliferation but not plasticity in T~regs~ stimulated under Th17 conditions. CPD-670 dilution (proliferation) (**a**), or Foxp3 expression (**b**), of T~reg~ cells co-cultured with conventional CD4+ T cells under Th17 conditions for four days, with or without Pam3CSK4, HKCA, or by themselves without (d4-no IL-2) or with IL-2 (d4-IL-2). CD45.2 T~regs~ are gated in the analyses. (**c**) T~regs~ were stimulated as in "a". Foxp3 and IL-17A expression of cells gated on CPD670+CD45.2 T~regs~ (upper panel), or CPD670-Foxp3-CD45.1 T~eff~ (lower panel) in co-cultures. (**d**) Foxp3 and CD4 expression (upper panel), of naïve cells that were stimulated under Th0 (Th0) or Th17 (Th17) conditions, or T~regs~ that were stimulated under Th17 (Th17 T~reg~) conditions. Foxp3 and IL-17A expression (lower panel), of the Foxp3+ cells in the upper panel. (**e**) Proliferation suppression of the CD4 responder cells (as in "2c") co-cultured with GFP^+^ T~reg~ cells isolated from cultures stimulated as in "a". Data represent three independent experiments.
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As we have shown previously, T~regs~ did not suppress effector Th17 cells (T~eff~) because of IL-6 and excess IL-2 in Th17 polarizing milieu \[[@B22-pathogens-04-00090]\], both in the presence or absence of TLR-2 ligands (data not shown). We then sought to determine whether T~regs~ retain their suppressive activity after the withdrawal of Th17 cytokines and TLR-2 agonists. Therefore we stimulated T~regs~ under Th17 inducing conditions, in the presence or absence of Pam3CSK4 and HKCA. After 4 days, we washed the T~regs~ (Th17 T~regs~) and co-cultured them with CPD-670 labeled CD4^+^CD25^−^naïve responder cells (T~resp~), in the presence of α-CD3 and APC \[[@B34-pathogens-04-00090]\]. As controls, we used T~effs~ (Th17 T~eff~) that were previously stimulated under Th17 inducing conditions in the presence or absence of TLR-2 ligands, and co-cultured them with T~resps~. As determined by T~resp~ CPD-670 dilution, we found that Th17 T~regs~ stimulated with TLR-2 agonists were capable inducing proliferation suppression in T~resps~ ([Figure 4](#pathogens-04-00090-f004){ref-type="fig"}e). These results demonstrate that T~regs~ produced IL-17A and lost their suppressive capacity only transiently in the presence of Th17 cytokines in the milieu. However, they were capable of suppressing CD4+ T cells upon pro-inflammatory cytokine and TLR-2 ligand withdrawal.

To further validate the role of TLR-2 ligands in induction IL-17A in Foxp3^+^T~regs~, we assessed the relative mRNA levels of *Tlr-2*, *Foxp3*, *IL-17A* and *ROR-γt* on d2 after stimulation. We used Th0 stimulated CD4^+^CD25^−^ Foxp3^GFP−^ cells as the normalizing control, unstimulated CD4^+^CD25^−^ Foxp3^GFP−^ cells, and CD90 depleted APC as additional controls. Compared to Th0 cells, both CD4 effector cells and T~regs~ had higher levels of *Tlr-2* mRNA expression under Th17 inducing conditions ([Figure 5](#pathogens-04-00090-f005){ref-type="fig"}a). As expected, Foxp3 mRNA expression was observed only in T~regs~ and was unchanged between un-stimulated T~regs~ and Th17 T~regs~ that were stimulated with and without Pam3CSK4 ([Figure 5](#pathogens-04-00090-f005){ref-type="fig"}b). However, Th17 T~regs~ expressed IL-17A and ROR-γt that were further up-regulated by Pam3CSK4 ([Figure 5](#pathogens-04-00090-f005){ref-type="fig"}c,d). Similar to mRNA expression, T~regs~ stimulated with Pam3CSK4 showed ROR-γt protein up-regulation, although at lower levels (MFI \~4--12) when compared to T~eff~ (MFI \~24--31) ([Figure 5](#pathogens-04-00090-f005){ref-type="fig"}e). Taken together, these results validate that although TLR-2 ligands induced proliferation and increased IL-17A and ROR-γt expression among Foxp3^+^T~regs~, they do not reprogram the cells or affect the stability of Foxp3 expression.

![T~regs~ up-regulate TLR-2, Foxp3, IL-17A and ROR-γt in the presence of Pam3CSK4 and Th17 conditions *in vitro*. Naïve cells or T~regs~ were stimulated under Th0 (Th0 stim) or Th17 (Th17 stim) conditions as in "4d", with or without Pam3CSK4. Unstimulated CD4 T cells (Unstim) and CD90 depleted APC activated with Pam3CSK4 were used as controls (APC). Two days later, RNA was isolated from CD90 sorted T cells from Th17 cultures, and relative mRNA levels of Tlr-2 (**a**), Foxp3 (**b**), IL-17A (**c**) and ROR-γt (**d**) were assessed using q-PCR. (**e**) ROR-γt expression of the cells, gated on Foxp3+ CD45.2 T~regs~ (upper panel), or Foxp3-CD45.1 T~eff~ (lower panel) in the co-cultures is shown. Geometric mean fluorescence intensities (MFI) are shown.](pathogens-04-00090-g005){#pathogens-04-00090-f005}

2.5. TLR-2 Ligands Induced IL-17A Production Is Only Partially Dependent on TLR-2 Expression in T~regs~
-------------------------------------------------------------------------------------------------------

We next investigated the requirement of TLR-2 receptor in induction of IL-17A in Foxp3^+^T~regs~. Myd88 is the critical adaptor molecule downstream of TLR-2 ligand stimulation \[[@B35-pathogens-04-00090]\], and therefore we examined whether Myd88 is required for IL-17A up-regulation. We isolated WT or *Myd88*^−/−^ T~regs~ and stimulated them under Th17 inducing conditions in the presence of WT APC with or without Pam3CSK4 and formaldehyde fixed *Candida albicans* hyphae (FCA). We found that the absence of Myd88 signaling in T~regs~ slightly reduced TLR-2 dependent IL-17A production in the presence of WT APC ([Figure 6](#pathogens-04-00090-f006){ref-type="fig"}a, top two panels, 6b). We then stimulated *Myd88*^−/−^ T~regs~ with *Myd88*^−/−^ APC in the presence or absence of TLR-2 ligands. Absence of Myd88 in APC further reduced the IL-17A induction almost to the basal levels in T~regs~ ([Figure 6](#pathogens-04-00090-f006){ref-type="fig"}a, third panel, 6b). Previous studies have shown TLR activation in APC can promote IL-6, a crucial cytokine for IL-17A induction in CD4 T cells \[[@B16-pathogens-04-00090],[@B19-pathogens-04-00090]\]. Accordingly, when we stimulated *Myd88*^−/−^ T~regs~ with WT APC in the presence of α-IL-6 neutralizing antibody, IL-17A was completely abolished in T~regs~ ([Figure 6](#pathogens-04-00090-f006){ref-type="fig"}a, bottom panel, 6b). To further validate the direct TLR-2 signaling requirement in induction of IL-17A in T~regs~, independent of TLR-2 expression in APC, we stimulated WT and *Tlr-2*^−/−^ T~regs~ with *Tlr-2*^−/−^ APC under Th17 inducing conditions. Only a fraction of both WT and *Tlr-2*^−/−^ T~regs~ produced IL-17A ([Figure 6](#pathogens-04-00090-f006){ref-type="fig"}c,d). However, Pam3CSK4 further promoted IL-17A expression only in WT T~regs~ but not in *Tlr-2*^−/−^ T~regs~. In the presence of FCA, IL-17A induction was only partially abrogated in *Tlr-2*^−/−^ T~regs~, showing that FCA mediated effects were only partially dependent on TLR-2 expression ([Figure 6](#pathogens-04-00090-f006){ref-type="fig"}c,d). Taken together, these data show that under Th17 inducing conditions, maximal induction of IL-17A requires both direct and indirect TLR-2/Myd88 signaling on T~regs~, as well as APC. IL-6 was a critical factor in the milieu for T~regs~ to produce IL-17A both in the presence and the absence of TLR-2 ligands.

2.6. Direct TLR-2 Signaling in T~regs~ is Required for Maximal Induction of Foxp3^+^ IL-17A+ Cells during OPC *in Vivo*
-----------------------------------------------------------------------------------------------------------------------

Lastly, we examined the requirement of TLR-2 expression for inducing IL-17A in T~regs~ during OPC *in vivo*. Although TLR-2 signaling promotes T~reg~ proliferation during systemic candidiasis, IL-17A induction was not assessed in T~regs~ during the infection \[[@B21-pathogens-04-00090]\]. To determine the role of TLR-2 signaling in induction of IL-17A in Foxp3+T~regs~*in vivo*, we orally infected WT and *Tlr-2^−/−^* mice and measured IL-17A production in CD4+ T cells. We found reduced frequency of T~regs~ in *Tlr-2^−/−^* mice compared to WT mice infiltrating the draining lymphnodes and MOIL during infection ([Figure 7](#pathogens-04-00090-f007){ref-type="fig"}a). Importantly, among those Foxp3+CD4+ T~regs~ the frequency of IL-17A producers was at least three to five times decreased in *Tlr-2^−/−^* mice than in WT mice ([Figure 7](#pathogens-04-00090-f007){ref-type="fig"}a,b). These data show that TLR-2 signaling enhances proliferation and maximal IL-17A induction in T~regs~. Consistent to the role of TLR-2 signaling in promoting IL-17A in effector CD4 cells \[[@B14-pathogens-04-00090]\], we also found reduced IL-17A production among Foxp3-effector CD4+ cells in *Tlr-2^−/−^* mice, when compared to the WT mice ([Figure 7](#pathogens-04-00090-f007){ref-type="fig"}a). To further confirm the direct role of TLR signaling in T~regs~, we used *Myd88^fl^°^x^ Foxp3^YFPcre^* mice, in which *Myd88* gene was conditionally deleted in Foxp3^+^ cells. Compared to the control *Foxp3^YFPcre^* infected mice, the induction of IL-17A was significantly reduced in *Myd88^fl^°^x^ Foxp3^YFPcre^* mice in Foxp3^+^ cells ([Figure 7](#pathogens-04-00090-f007){ref-type="fig"}c,d lower panel). Although there was a slight decrease in IL-17A production even in the effector cells in MOIL, the frequency of IL-17A producing effector cells was unchanged between the groups in CLN and ALN ([Figure 7](#pathogens-04-00090-f007){ref-type="fig"}c,d upper panel). Taken together, these results reveal that direct TLR-2 signaling in T~regs~ plays a crucial role in increasing IL-17A+Foxp3+ T~regs~ during OPC *in vivo*.

![IL-17A production of T~regs~ in an inflammatory milieu is dependent on TLR-2 expression in T~regs~ and APC. (**a**,**b**) WT or Myd88^−/−^ T~regs~ were stimulated with WT APC or Myd88^−/−^ APC as indicated, without or with Pam3CSK4 or fixed *Candida albicans* (FCA) germ tube for four days. Foxp3 and IL-17A expression (**a**), and statistical representation of IL-17A expression in Foxp3+ T~regs~ (**b**). α-IL-6 antibodies were added under Th17 conditions without exogenous IL-6 (**a**, bottom panel). (**c**,**d**) WT or Tlr-2^−/−^ T~regs~ were stimulated with Tlr-2^−/−^ APC, without or with Pam3CSK4 or FCA for 4 days. Foxp3 and IL-17A expression in CD4 gated cells (**c**), and statistical representation of IL-17A expression (**d**), are shown. Data represent at least 3 independent experiments.](pathogens-04-00090-g006){#pathogens-04-00090-f006}

![IL-17A expression in CD4^+^ Foxp3^+^ T~regs~ requires TLR-2 signaling in T~regs~ during *C. albicans* infection *in vivo*. WT C57BL/6 or Tlr-2^−/−^ mice infected with *C. albicans*, and tissues were isolated as in "1a". Flow cytometric plots gated on CD4+ cells showing IL-17A expression (**a**), and statistical analyses of IL-17A expression in CD4+Foxp3+ cells (**b**) are shown. Data represent triplicate experiments. (**c**,**d**) Foxp3^YFPcre^ or Myd88 ^fl^°^x^ Foxp3^YFPcre^ mice were infected, and cells were isolated as in "1a". Flow cytometric plots gated on or CD4+ cells showing IL-17A expression (**c**), and statistical analyses of IL-17A expression in CD4+Foxp3-cells (**d**, upper panel) and CD4+Foxp3+ cells (d, lower panel) are shown.](pathogens-04-00090-g007){#pathogens-04-00090-f007}

3. Discussion
=============

Foxp3+T~regs~ produce little or no IL-17A in a sterile environment such as thymus in humans or in naïve mice raised under specific pathogen free conditions \[[@B6-pathogens-04-00090]\]. Voo *et al.*, were one of the first groups to show the enrichment of peripherally generated IL-17A+T~regs~ in tonsils, compared to blood, in individuals undergoing tonsillectomy \[[@B6-pathogens-04-00090]\]. As tonsils constitute an oral mucosal environment, we hypothesized that oral infections may lead to the generation of these IL-17A+Foxp3+ cells. To verify the tenet, we examined whether they could be induced during oropharyngeal candidiasis infection in mice. Our study shows that OPC can induce Foxp3+IL-17A+T~regs~ (T~reg~-17) in a TLR-2/Myd88 dependent manner, revealing one of the mechanisms by which T~reg~-17 cells are induced during inflammation. We also show that while TLR-2 ligands promote only proliferation in the context of non-inflammatory homeostatic conditions, they can increase proliferation and IL-17A production in T~regs~ in the context of APC and inflammatory conditions. Although some of these data are in line with the reports that showed TLR-2 signaling induces survival and proliferation in T~regs~ activated by TCR \[[@B12-pathogens-04-00090],[@B17-pathogens-04-00090]\], our study also unveils a novel function of TLR-2 in IL-2 dependent homeostatic proliferation of T~regs~. Reduced tT~regs~ and pT~regs~ in *Tlr-2*^−/−^ mice demonstrate that TLR-2 ligands from commensals play a role in maintaining their steady state proliferation ([Figure 3](#pathogens-04-00090-f003){ref-type="fig"}b,d). Although TLR-2 signaling was not examined, defective T~regs~ in germfree and antibiotic treated mice in previous studies \[[@B36-pathogens-04-00090],[@B37-pathogens-04-00090],[@B38-pathogens-04-00090],[@B39-pathogens-04-00090],[@B40-pathogens-04-00090]\] further confirm the role of commensals in maintaining T~regs~ in the gut. Further strengthening the idea that TLR-2 signaling induces proliferation of T~regs~ *in vivo*, and similar to a previous study \[[@B21-pathogens-04-00090]\], we observed reduced T~regs~ at the site of infection in *C. albicans* infected *Tlr-2*^−/−^ mice compared to WT mice. CD4 effector cells and T~regs~ showed higher TLR-2 protein expression in Th17 inflammatory conditions, compared to Th0 cultures ([Figure 5](#pathogens-04-00090-f005){ref-type="fig"}a), showing that Th17 inflammatory cytokines may promote enhanced TLR-2 signaling and proliferation in CD4+T cells \[[@B14-pathogens-04-00090]\]. However, contrary to previous findings \[[@B15-pathogens-04-00090]\], TLR-2 ligands did not lead to loss of Foxp3 expression. Although under Th17 inflammatory milieu, T~regs~ did not suppress CD4+ cells, and lost Foxp3 transiently \[[@B22-pathogens-04-00090]\], T~regs~ that expanded with TLR-2 agonists were capable of suppressing fresh CD4+ T cells, upon IL-6 withdrawal. These data imply that the reversal of suppression by TLR-2 agonists in previous studies is likely due to the cytokines in effector CD4 T cells and APC induced by TLR-2 ligands, but not due to their direct effect on T~regs~ \[[@B15-pathogens-04-00090]\]. Apparent loss of Foxp3 expression could also be due to the usage of CD4^+^CD25^+^ cells in some studies, instead of CD4^+^CD25^+^Foxp3^+^ cells, that might have led to proliferation of Foxp3^−^ cells in their cultures.

Although TLR-2 ligands can directly induce proliferation of T~reg~-17 cells, maximal IL-17A induction in T~regs~ requires IL-6, and TLR-2/Myd88 signaling in APC as well. Mechanistically, although it is conceivable that IL-6 may prime IL-17A induction in Foxp3+T~regs~ \[[@B6-pathogens-04-00090]\], we report here for the first time the role of TLR-2 signaling in increasing the frequency of T~reg~-17 cells, by promoting proliferation of IL-17A producing Foxp3+T~regs~ *in vitro* and *in vivo*. However, the lower levels of ROR-γt and IL-17A that we observed in T~regs~ when compared to the effector cells, is likely due to the inhibitory effect of Foxp3 on ROR-γt expression \[[@B41-pathogens-04-00090],[@B42-pathogens-04-00090]\]. In the context of *Candida albicans*, even in the absence of TLR-2 signaling in both T~regs~ and APC, FCA could partially induce IL-17A in T~regs~. We speculate that dectin-1 or 2 signaling is also involved in the induction of IL-17A by *C. albicans* \[[@B43-pathogens-04-00090]\]. However, our results showing diminished production of IL-17A in effector CD4+ cells and T~regs~ in *Tlr-2*^−/−^ mice*,* underscore the importance of *Candida* derived TLR-2 ligands, in orchestrating effector functions and induction of T~reg~-17 cells during OPC. T~reg~-17 cells that we describe herein can be induced both from a fraction of tT~regs~ and iT~reg~ cells induced in cultures ([Figure 4](#pathogens-04-00090-f004){ref-type="fig"}d). Similarly, T~reg~-17 cells are possibly derived from tT~regs~ and pT~regs~ during OPC *in vivo* as well. Whether these T~reg~-17 cells also play roles in direct antifungal Th17 responses remain to be investigated. This tenet would be consistent with the requirement of T~regs~ in protective immunity to fungi \[[@B24-pathogens-04-00090]\]. However, in the context of suppressing inflammation, Foxp3+ T~regs~ undergo effector specific functional adaptation in order to suppress distinct effector responses\[[@B44-pathogens-04-00090]\]. For example, T~regs~ acquire effector Tfh characteristics such as Bcl6 and CXCR5 expression to regulate Tfh and germinal center responses in a Bcl-6 dependent manner \[[@B45-pathogens-04-00090],[@B46-pathogens-04-00090]\]. Likewise, they require IRF-4 and STAT-3 signaling to suppress Th2 and Th17 immunopathology, respectively, *in vivo* \[[@B44-pathogens-04-00090],[@B47-pathogens-04-00090]\]. However, it is unknown if T~regs~ with active STAT-3 signaling express IL-17A to adapt to their environment and engage distinct effector response---specific suppression of Th17 immunopathology. If this is the case, T~reg~-17 cells promoted by TLR-2 ligands and Th17 cytokines may be a specific population of T~regs~ programed for antimicrobial functions at early time-points, and for controlling Th17 pathology at later phases of infection. Supporting this notion, the T~reg~ population, which included the effector T~reg~-17 cells, while enhancing IL-17A in Th17 cells initially, was capable of suppressing OPC immunopathology and IBD immunopathology at later time points in our studies (\[[@B22-pathogens-04-00090]\], [Figure S1](#app1-pathogens-04-00090){ref-type="app"}b). Also *in vitro*, despite acquiring effector functions, \>90% of CD25+Foxp3+ T~regs~ had stable Foxp3 expression, and retained their suppressive properties, upon IL-6 and TLR-2 ligand withdrawal ([Figure 4](#pathogens-04-00090-f004){ref-type="fig"}e). Taken together, these data provide important insights into the role of TLR-2 signaling in promoting T~reg~-17 populations without affecting their suppressive properties during inflammation and infections. We believe that during mucosal inflammation, TLR-2 ligands from commensals and pathogens may drive effector cytokine production in T~regs~. Although in the context of local IL-6, T~regs~ lose their suppressive functions and produce effector cytokines transiently, TLR-2 ligands do not lead to their terminal differentiation in to effector cells. Future studies are warranted to further examine the precise functions of T~reg~-17 cells during infections and homeostasis in mucosal environments in human diseases.

4. Materials and Methods
========================

4.1. Mice
---------

C57BL/6, Balb/C, C57BL/6 WT, *Tlr-2*^−/−^, *Il17a*^−/−*cre*^ and *Myd88*^−/−^, *Foxp3^GFP^* reporter mice, *Foxp3^YFPcre^* reporter mice and *Myd88^fl^°^x^* mice were purchased from Jackson Laboratories and were used at 8--12 weeks of age. *Myd88^fl^°^x^ Foxp3^YFPcre^* mice were generated by breeding *Foxp3^YFPcre^* reporter mice and *Myd88^fl^°^x^* mice, and *Foxp3^YFPcre^* littermates were used as controls. All the mice were maintained in the Animal Resource Center at Case Western Reserve University and cared for in accordance with institutional guidelines and approved IACUC protocols.

4.2. Reagents and Antibodies
----------------------------

Purified α-CD3 (145-2C11), purified α-CD28, α-CD25 (3C7), Biotin α-CD25, fluorescein isothiocyanate (FITC)-α-CD4, phycoerythrin (PE)-α-CD25, unconjugated, (allophycocyanin) APC, Alexafluor-647 or PE conjugated α-CD44, APC, Alexafluor 647, PE or PE-Cy7 conjugated IL-17-A, Foxp3 antibodies, IL-6 blocking antibodies, α-IL-4 and IFN-γ antibodies, were all purchased from eBiosciences (San Diego, CA). Mouse CD4 isolation kit II was purchased from Miltenyi Biotec (Auburn, CA). EasySep isolation kits were purchased from Stem Cell technologies (Canada). Human IL-2 purchased from NCI, was a kind gift from Mike Lenardo lab (NIAID, NIH). Recombinant mouse IL-6 was purchased from BioBasic Inc (Amherst, NY), and human TGF-β was purchased from R&D Systems (Minneapolis, MN). Mouse cells were cultured in complete RPMI-1640 (Bio-Whittaker) supplemented with 10% FCS, 100 U/mL penicillin, 100 μg/mL streptomycin, 5 mM Glutamax (Invitrogen) and 50 μM β-mercaptoethanol.

4.3. Cell Purification
----------------------

Splenocytes and lymphnodes were harvested from 8- to 12-week-old mice and pooled. CD4 cells were MACS (magnetic assisted cell sorting) purified by using CD4 isolation kit II (Miltenyi Biotec, Auburn, CA) or sorted using EasySep kits. Purified CD4 cells were FACS (Fluorescence Activated Cell Sorting) sorted for CD4^+^CD25^−^GFP^−^ T~con~ cells or CD4^+^CD25^+^ GFP^+^ T~reg~ cells (\>99% purity). In some experiments CD25^+^ T~regs~ and CD4^+^CD25^−^ CD44^l^°^w^ naïve T~con~ cells were sorted using EasySep kits, and the purity of T~regs~ was more than 92%. 6 × 10^4^ FACS sorted T~cons~ or T~regs~ were cultured in U-bottom 96 well plates with 2 ng/mL IL-2 only, or also with TLR ligands. Pam3CSK4, heat killed *Candida albicans* (HKCA), Lipopolysaccharide (LPS), and Flagellin were purchased at Invivogen and were used at following concentrations: LPS, 1 ug/mL; Flagellin, 1μg/mL; Pam3CSK4, 5 μg/mL and HKCA, 10^6^/mL. In some experiments, formaldehyde fixed *Candida albicans* germtube (FCA) were used at 10^6^/mL.

4.4. Th17 Differentiation
-------------------------

T~reg~ cells were cultured alone in U-bottom 96 well plates, or co-cultured with T~cons~ in the presence of soluble 1 μg/mL of α-CD3 and 2 μg/mL α-CD28 antibodies under Th17 inducing conditions for 3--4 days. Th17 cells were polarized using recombinant mouse IL-6 (25 ng/mL), recombinant human TGF-β (2 ng/mL), recombinant mouse IL-23 (20 ng/mL), recombinant mouse IL-1β (20 ng/mL), α-IFN-γ (3 μg/mL) and α-IL-4 (3 μg/mL). T cell depleted splenocytes were added as antigen presenting cells (APC) in the cultures. T~cons~ were derived from congenic CD45.1 mice, and T~regs~ were derived from CD45.2 B6 Foxp3^GFP^ reporter mice so that T~regs~ could also be tracked using CD45.2 staining. In some experiments, where α-IL-6 antibody was added, we restimulated day-1 Th17 cells under Th17 inducing conditions without adding exogenous IL-6. For "Th0" conditions, cells were stimulated with α-CD3, α-CD28, APC and IL-2 (10 ng/mL). For flow cytometry analyses of IL-17A staining, we used unstained controls and stained Th0 cells as negative controls, to define the gates and mark IL-17A+ cells.

4.5. Quantitative PCR (q-PCR) Analyses
--------------------------------------

To measure the relative mRNA levels of TLR-2, Foxp3, ROR-γt and IL-17A, RNA was recovered from T~regs~ or T~cons~ using EZ-10 RNA isolation kit (BioBasic). Genomic DNA was removed by DNA Away (Ambion; LifeTechnologies (AM1906)) and cDNA was synthesized from using MuLV reverse transcriptase enzyme (BioBasic) and OligodT primers. qPCR reaction was performed using SYBR Green PCR Kit (BioBasic) in a real time PCR machine (BioRad). The relative levels were normalized to the amount of β-actin cDNA levels. The following primer sequences were used: β-actin: 5\'-AGCCATGTACGTAGCCATCC-3\', 5\'-CTCTCAGCTGTGGTGGTGAA-3\', TLR-2: 5\'-CCGGAATTATCAGTCCCAAA-3\', 5\'-ATCTCCAGCAGGAAAGCAGA-3\', ROR-γt: 5\'-AACAGGAACAAGTGGCCAAG-3\', 5\'-GGTAGCTGCCCATCTGAGAG-3\', FoxP3: 5\'-TTCATGCATCAGCTCTCCAC-3\', 5\'-TGATCATGGCTGGGTTGTC-3\', IL-17A: 5\'-AAAGCTCAGCGTGTCCAAA-3\', 5\'-GCGCCAAGGGAGTTAAAGAC-3\'.

4.6. C. albicans Infection in Mice
----------------------------------

Age and sex matched mice were infected and individually caged after infection, as previously described \[[@B22-pathogens-04-00090],[@B48-pathogens-04-00090]\]. They were infected under anesthesia by placing a 3 mm diameter cotton ball saturated with PBS (Sham) or 2 × 10^7^ *C. albicans* (CAF2-1) blastospores sublingually for 90 min. Spleen, ALN, CLN, and MOIL were harvested, one or two days after infection for phorbol myrisate acetate (PMA), ionomycin and brefeldin-A re-stimulation, and intracellular cytokine analyses.

4.7. IBD Induction by Th17 Cell Transfer *in Vivo*
--------------------------------------------------

For Th17 IBD, CD45.1 *Rag1*^−/−^ mice received 8 × 10^5^ CD45.1 Th17 cells that were stimulated and differentiated for 5 days as above. Two weeks later, the mice received fresh CD45.2 T~regs~ derived from congenic CD45.2 Foxp3^GFP^ reporter mice. Spleen, MLN and the gut LP cells were harvested 5 days after T~reg~ injection, for PMA/ionomycin/brefeldin-A re-stimulation and intracellular cytokine analyses.

4.8. Statistical Analyses
-------------------------

p values were calculated by Students "t" test in Microsoft Excel software using two tailed distribution and two-sample equal variance parameters, with \*\* being *p* \< 0.05. We also used Mann-Whitney tests, or 2 way ANOVA Sidak's multiple comparisons test (alpha value 0.05; 95% CI) in Prism 6.0 (GraphPad Software, Inc.) to calculate significance.

5. Conclusions
==============

CD4^+^Foxp3^+^T~regs~ produce the effector cytokine IL-17A *in vitro* and *in vivo* during oropharyngeal candidiasis (OPC) in a TLR-2/Myd88 signaling dependent manner. We call these cells as T~reg~-17 cells. Although TLR-2/Myd88 signaling can directly induce proliferation of T~reg~-17 cells, maximal IL-17A induction in T~regs~ requires IL-6, and TLR-2 signaling in APC as well. The minimal and transient loss of Foxp3 expression and suppressive properties are due to the presence of IL-6 in the milieu, but not the direct effect of TLR-2 signaling in T~regs~. Taken together, our data reveal that TLR-2 signaling promotes not only proliferation, but also IL-17A in T~regs~, depending on the cytokine milieu. These T~reg~-17 cells may be relevant in mucosal infections and inflammation.
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